Human Angiostrongylus cantonensis: an update

Angiostrongylus cantonensis was first discovered in 1935 and has become an important emerging pathogen causing human angiostrongyliasis. Major outbreaks of human angiostrongyliasis have been reported in endemic regions. Thousands of cases of human angiostrongyliasis have been documented worldwide. A...

Full description

Saved in:
Bibliographic Details
Published in:European journal of clinical microbiology & infectious diseases 2012-04, Vol.31 (4), p.389-395
Main Authors: Wang, Q.-P., Wu, Z.-D., Wei, J., Owen, R. L., Lun, Z.-R.
Format: Article
Language:English
Subjects:
Adrenal Cortex Hormones - therapeutic use
Adults
Angiostrongylus cantonensis - isolation & purification
Angiostrongylus cantonensis - pathogenicity
Animals
Anthelmintics - therapeutic use
Anti-Inflammatory Agents - therapeutic use
Biomedical and Life Sciences
Biomedicine
Corticoids
Disease Outbreaks
Endemic Diseases
Epidemiology
Feces
Feeding Behavior
Foodborne Diseases - drug therapy
Foodborne Diseases - epidemiology
Foodborne Diseases - parasitology
Foodborne Diseases - pathology
Global Health
Humans
Infections
Internal Medicine
Islands
Medical Microbiology
Meningitis
Mollusks
Nausea
Nervous system
Parasites
Pathogens
Proteins
Pulmonary arteries
Review
Steroids
Strongylida Infections - drug therapy
Strongylida Infections - epidemiology
Strongylida Infections - parasitology
Strongylida Infections - pathology
Tropical diseases
Vomiting
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Angiostrongylus cantonensis was first discovered in 1935 and has become an important emerging pathogen causing human angiostrongyliasis. Major outbreaks of human angiostrongyliasis have been reported in endemic regions. Thousands of cases of human angiostrongyliasis have been documented worldwide. A. cantonensis has spread from its traditional endemic regions of the Pacific islands and Southeast Asia to the American continent including the USA, Caribbean islands and Brazil. Humans acquire A. cantonensis by consumption of raw or undercooked intermediate snail hosts or paratenic hosts. The main clinical manifestations of human angiostrongyliasis are eosinophilic meningitis and ocular angiostrongyliasis. The treatment of this disease includes supportive treatment, corticosteroid therapy, and combined therapy with corticosteroids and anthelminthics. The most effective method for prevention is to persuade people not to eat raw or undercooked intermediate and paratenic hosts.
ISSN:0934-9723
1435-4373
DOI:10.1007/s10096-011-1328-5